4.4 Article

Functions of Genes and Enzymes Involved in Phenalinolactone Biosynthesis

期刊

CHEMBIOCHEM
卷 11, 期 10, 页码 1383-1391

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.201000117

关键词

natural products; oxygenases; phenalinolacone; Streptomyces; terpenoids

资金

  1. BMBF
  2. Landesgraduiertenforderung Baden Wurttemberg

向作者/读者索取更多资源

Phenalinolactones are novel terpene glycoside antibiotics produced by Streptomyces sp. Tu6071. Inactivation of three oxygenase genes (plaO2, plaO3 and plaO5), two dehydrogenase genes (plaU, plaZ) and one putative acetyltransferase gene (play) led to the production of novel phenalinolactone derivatives (PL HS6, PL HS7, PL HS2 and PL X1). Furthermore, the exact biosynthetic functions of two enzymes were determined, and their in vitro activities were demonstrated. PlaO1, an Fe-II/alpha-ketoglutarate-dependent dioxygenase, is responsible for the key step in gamma-butyrolactone formation, whereas PlaO5, a cytochrome P450-dependent monooxygenase, catalyses the 1-C-hydroxylation of phenalinolactone D. In addition, stable isotope feeding experiments with biosynthetic precursors shed light on the origin of the carbons in the gamma-butyrolactone moiety.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

Darobactins Exhibiting Superior Antibiotic Activity by Cryo-EM Structure Guided Biosynthetic Engineering

Carsten E. Seyfert, Christoph Porten, Biao Yuan, Selina Deckarm, Fabian Panter, Chantal D. Bader, Janetta Coetzee, Felix Deschner, Kamaleddin H. M. E. Tehrani, Paul G. Higgins, Harald Seifert, Thomas C. Marlovits, Jennifer Herrmann, Rolf Mueller

Summary: In recent decades, the pipeline for antibiotics targeting Gram-negative bacteria has become depleted due to the insufficiency in potency, pharmacokinetic properties, and toxicity of most discovered candidates. A new class of promising drug candidates called darobactins has been developed, which bind to a novel antibiotic target called BamA, an outer membrane protein. This study presents the cryo-EM structures of the Bam complex with darobactin 9 (D9) and the biotechnological generation of twenty new darobactins, including halogenated analogs, using an optimized purification method. The newly engineered darobactin 22 binds more effectively to BamA and exhibits 32-fold improved activity against clinically relevant pathogens such as carbapenem-resistant Acinetobacter baumannii, without any observed toxic effects.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Chemistry, Multidisciplinary

Persicamidines-Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses

Lena Keller, Emilia Oueis, Amninder Kaur, Nasim Safaei, Susanne H. Kirsch, Antonia P. Gunesch, Sibylle Haid, Ulfert Rand, Luka Cicin-Sain, Chengzhang Fu, Joachim Wink, Thomas Pietschmann, Rolf Mueller

Summary: A new strain of actinobacteria, Kibdelosporangium persicum sp. nov., collected from a hot desert in Iran, yielded a novel family of sesquarterpenoids (persicamidines A-E) with remarkable antiviral activity. Extensive NMR analysis revealed a hexacyclic terpenoid molecule with a modified sugar moiety on one side and a unique isourea moiety fused to the terpenoid structure. Persicamidines A-E exhibited potent activity against hCoV-229E and SARS-CoV-2 viruses in the nanomolar range, along with excellent selectivity indices, showing promise as potential drug candidates.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Biochemistry & Molecular Biology

Pineapple Lectin AcmJRL Binds SARS-CoV-2 Spike Protein in a Carbohydrate-Dependent Fashion

Joscha Meiers, Jan Dastbaz, Sebastian Adam, Sari Rasheed, Susanne H. Kirsch, Peter Meiser, Peter Gross, Rolf Mueller, Alexander Titz

Summary: The highly glycosylated spike protein of SARS-CoV-2 is crucial for infection and is a target for antiviral agents and vaccines. A pineapple-derived lectin AcmJRL has been found to bind mannosides and is present in the medication bromelain. This study showed that AcmJRL binds to the spike protein of SARS-CoV-2 with a low-micromolar K-D in a carbohydrate-dependent manner.

CHEMBIOCHEM (2023)

Editorial Material Biochemistry & Molecular Biology

Current developments in antibiotic discovery Global microbial diversity as a source for evolutionary optimized anti-bacterials

Julian D. Hegemann, Joy Birkelbach, Sebastian Walesch, Rolf Mueller

EMBO REPORTS (2023)

Review Biochemistry & Molecular Biology

Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials

Sebastian Walesch, Joy Birkelbach, Gwenaelle Jezequel, F. P. Jake Haeckl, Julian D. Hegemann, Thomas Hesterkamp, Anna K. H. Hirsch, Peter Hammann, Rolf Mueller

Summary: Antibacterial resistance is a significant threat to human health, and the development of new therapeutics has slowed down since the first antibiotics were approved in the 20(th) century. Most of the current drug leads are modifications of existing antibacterials, many of which come from natural products. This review highlights the challenges, advancements, and current status of the clinical and preclinical antibacterial research pipeline, and advocates for renewed investment and enthusiasm in the antibacterial discovery process.

EMBO REPORTS (2023)

Article Chemistry, Medicinal

Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl) isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization

Miriam Girardini, Francesca Ferlenghi, Giannamaria Annunziato, Giulia Degiacomi, Bianca Papotti, Cinzia Marchi, Jose Camilla Sammartino, Sari S. Rasheed, Anna Contini, Maria Rosalia Pasca, Federica Vacondio, Joanna C. Evans, Thomas Dick, Rolf Mueller, Gabriele Costantino, Marco Pieroni

Summary: Tuberculosis is a deadly infectious disease and the increase in drug-resistant strains is concerning. Previous studies have identified compounds with inhibitory activity against Mycobacterium tuberculosis strains. In this study, researchers aimed to determine the metabolic fate of these compounds and explore structural modifications to improve activity and avoid rapid clearance. Novel antitubercular chemotypes were also investigated. The findings led to the design of improved compounds with good activity against drug-susceptible and drug-resistant strains.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Identification of Compounds Preventing A. fumigatus Biofilm Formation by Inhibition of the Galactosaminogalactan Deacetylase Agd3

Carla I. I. Seegers, Danielle J. Lee, Patricia Zarnovican, Susanne H. Kirsch, Rolf Mueller, Thomas Haselhorst, Francoise H. Routier

Summary: The opportunistic fungus Aspergillus fumigatus causes various diseases and forms a biofilm that protects it from the host's immune defenses and antifungal drugs. This study discovered drugs that inhibit biofilm synthesis and disrupt existing biofilms, including Actinomycin X2, Actinomycin D, Rifaximin, and Imatinib.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Plant Sciences

Structure Elucidation and Biosynthesis of Nannosterols A and B, Myxobacterial Sterols from Nannocystis sp. MNa10993

Sergi H. Akone, Joachim J. Hug, Amninder Kaur, Ronald Garcia, Rolf Mueller

Summary: The study reports the discovery, isolation, structure elucidation, and biological evaluation of two new bacterial sterols, nannosterols A and B, from the terrestrial myxobacterium Nannocystis sp. These nannosterols features unique modifications and chemical features, such as a secondary alcohol group at position C-15 and a terminal vicinal diol side chain at C-24-C-25, which have not been observed in bacterial sterols before. The investigation based on myxobacterial high-resolution secondary metabolome data and genomic in silico investigations revealed that nannosterols are frequently produced sterols within the myxobacterial suborder of Nannocystineae. The discovery of nannosterols provides insights into the biosynthesis and evolution of sterols by prokaryotes.

JOURNAL OF NATURAL PRODUCTS (2023)

Article Chemistry, Multidisciplinary

Unusual peptide-binding proteins guide pyrroloindoline alkaloid formation in crocagin biosynthesis

Sebastian Adam, Dazhong Zheng, Andreas Klein, Carsten Volz, William Mullen, Sally L. Shirran, Brian O. Smith, Olga V. Kalinina, Rolf Mueller, Jesko Koehnke

Summary: In this study, we identified three proteins (CgnB, CgnC, and CgnE) responsible for the production of the tetracyclic crocagin core. Crystal structures of two homologues (CgnB and CgnE) provided insights into their functions. We also discovered the roles of CgnD and CgnL in the liberation and modification of the crocagin core, respectively, and proposed a biosynthetic scheme. Bioinformatic analyses further revealed potential pathways for the synthesis of structurally diverse peptide-derived pyrroloindoline alkaloids.

NATURE CHEMISTRY (2023)

Article Microbiology

The Disorazole Z Family of Highly Potent Anticancer Natural Products from Sorangium cellulosum: Structure, Bioactivity, Biosynthesis, and Heterologous Expression

Yunsheng Gao, Joy Birkelbach, Chengzhang Fu, Jennifer Herrmann, Herbert Irschik, Bernd Morgenstern, Kerstin Hirschfelder, Ruijuan Li, Youming Zhang, Rolf Jansen, Rolf Mueller

Summary: Microbial secondary metabolites are abundant sources of bioactive compounds and are privileged scaffolds for the development of new drugs. Therefore, continuous discovery of novel bioactive natural products is crucial for pharmaceutical research. Myxobacteria, particularly Sorangium spp., are known for their underexploited biosynthetic potential and serve as proficient producers of such secondary metabolites. In this study, a family of natural products called disorazole Z was isolated and characterized from Sorangium cellulosum strain So ce1875, showing potent anticancer activity. Furthermore, the biosynthesis and heterologous production of disorazole Z were reported, providing potential for the development of disorazole-based anticancer drugs for clinical studies.

MICROBIOLOGY SPECTRUM (2023)

Article Chemistry, Multidisciplinary

Insights into the biosynthesis of icumazole, unveiling a distinctive family of crotonyl-CoA carboxylase/reductase

Feng Xie, Alexander F. Kiefer, Anna K. H. Hirsch, Olga V. Kalinina, Chengzhang Fu, Rolf Mueller

Summary: This study presents the polyketide synthase (PKS)/non-ribosomal peptide synthetase (NRPS) hybrid biosynthetic gene cluster of icumazoles. It is found that an unusual nonterminal thioesterase domain divides the PKS/NRPS assembly line, and the succeeding PKS modules potentially form a rare precursor 4-methyl-2-hexenoyl-ACP. The characterization of IcuL and its homologs TgaD and Leu10 suggests a stricter substrate specificity of this new family of crotonyl carboxylases/reductases (CCRs) than canonical ones, and TgaD shows unprecedented utilization of both NADPH and NADH as cofactors.

CELL REPORTS PHYSICAL SCIENCE (2023)

Article Chemistry, Multidisciplinary

Revision of the Absolute Configurations of Chelocardin and Amidochelocardin

Asfandyar Sikandar, Alexander Popoff, Ravindra P. Jumde, Attila Mandi, Amninder Kaur, Walid A. M. Elgaher, Lara Rosenberger, Stephan Huettel, Rolf Jansen, Maja Hunter, Jesko Koehnke, Anna K. H. Hirsch, Tibor Kurtan, Rolf Mueller

Summary: The absolute configuration of amidochelocardin was revised using a combination of XRD, NMR spectroscopy, experimental ECD spectra, and TDDFT-ECD calculations. Based on the biosynthetic engineering of chelocardin and the results of TDDFT-ECD calculations, it is proposed that chelocardin has the same absolute configuration. The evaluation of spectral data of two related analogues further supports this conclusion.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Review Biotechnology & Applied Microbiology

Artificial intelligence for natural product drug discovery

Michael W. Mullowney, Katherine R. Duncan, Somayah S. Elsayed, Neha Garg, Justin J. J. van der Hooft, Nathaniel I. Martin, David Meijer, Barbara R. Terlouw, Friederike Biermann, Kai Blin, Janani Durairaj, Marina Gorostiola Gonzalez, Eric J. N. Helfrich, Florian Huber, Stefan Leopold-Messer, Kohulan Rajan, Tristan de Rond, Jeffrey A. van Santen, Maria Sorokina, Marcy J. Balunas, Mehdi A. Beniddir, Doris A. van Bergeijk, Laura M. Carroll, Chase M. Clark, Djork-Arne Clevert, Chris A. Dejong, Chao Du, Scarlet Ferrinho, Francesca Grisoni, Albert Hofstetter, Willem Jespers, Olga V. Kalinina, Satria A. Kautsar, Hyunwoo Kim, Tiago F. Leao, Joleen Masschelein, Evan R. Rees, Raphael Reher, Daniel Reker, Philippe Schwaller, Marwin Segler, Michael A. Skinnider, Allison S. Walker, Egon L. Willighagen, Barbara Zdrazil, Nadine Ziemert, Rebecca J. M. Goss, Pierre Guyomard, Andrea Volkamer, William H. Gerwick, Hyun Uk Kim, Rolf Mueller, Gilles P. van Wezel, Gerard J. P. van Westen, Anna K. H. Hirsch, Roger G. Linington, Serina L. Robinson, Marnix H. Medema

Summary: The developments in computational omics technologies in combination with artificial intelligence approaches have opened up new possibilities for drug discovery. However, addressing key challenges such as high-quality datasets and algorithm validation is essential to realize the potential of these synergies.

NATURE REVIEWS DRUG DISCOVERY (2023)

Article Infectious Diseases

In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates

Mariam Rima, Niels Pfennigwerth, Martina Cremanns, Katarina Cirnski, Saoussen Oueslati, Soeren G. Gatermann, Nicola d'Amelio, Jennifer Herrmann, Rolf Mueller, Thierry Naas

Summary: The development of novel antibiotics is crucial to combat the growing problem of antibiotic resistance. In this study, the activity spectrum of cystobactamids and chelocardins, two promising classes of molecules with different modes of action, was determined. These molecules showed potent activities against clinically relevant Gram-negative and Gram-positive bacteria, including multi-drug resistant strains. The findings suggest that cystobactamid CN-DM-861 and chelocardin CDCHD have interesting antibiotic activities on MDR or XDR bacteria without cross-resistance to clinically relevant antibiotics.

ANTIBIOTICS-BASEL (2023)

Article Biotechnology & Applied Microbiology

Nobachelins, new siderophores from Nocardiopsis baichengensis protecting Caenorhabditis elegans from Pseudomonas aeruginosa infection

Haowen Zhao, Yuhao Ren, Feng Xie, Huanqin Dai, Hongwei Liu, Chengzhang Fu, Rolf Mueller

Summary: In this study, a new group of catecholate-hydroxamate siderophores, nobachelins, was discovered from Nocardiopsis baichengensis DSM 44845 by correlating a cryptic biosynthetic gene cluster to chemical molecules. Nobachelins, featuring fatty-acylated hydroxyornithine and a rare chlorinated catecholate group, were found to rescue Caenorhabditis elegans from Pseudomonas aeruginosa-mediated killing.

SYNTHETIC AND SYSTEMS BIOTECHNOLOGY (2023)

暂无数据